Biohaven Return on Investment 2016-2023 | BHVN
Current and historical return on investment (ROI) values for Biohaven (BHVN) over the last 10 years.
| Biohaven ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2023-03-31 |
$-0.34B |
|
3336.59% |
| 2022-12-31 |
$-0.35B |
|
-1114.96% |
| 2022-09-30 |
$-0.07B |
|
-211.02% |
| 2022-06-30 |
$-0.05B |
$-0.04B |
-139.35% |
| 2022-03-31 |
$0.06B |
$0.17B |
1828.57% |
| 2021-12-31 |
$-0.08B |
|
203.73% |
| 2021-09-30 |
$-0.07B |
$0.03B |
103.50% |
| 2021-06-30 |
$-0.18B |
$-0.18B |
275.76% |
| 2021-03-31 |
$-0.17B |
$-0.01B |
834.15% |
| 2020-12-31 |
$-0.09B |
$-0.13B |
458.67% |
| 2020-09-30 |
$-0.61B |
$0.05B |
-4880.00% |
| 2020-06-30 |
$-0.54B |
|
inf% |
| 2020-03-31 |
$-0.58B |
|
inf% |
| 2019-12-31 |
$-0.48B |
|
inf% |
| 2019-09-30 |
$-0.39B |
|
inf% |
| 2019-06-30 |
$-0.36B |
|
inf% |
| 2019-03-31 |
$-0.20B |
|
inf% |
| 2018-12-31 |
$-0.22B |
|
inf% |
| 2018-09-30 |
$-0.20B |
|
inf% |
| 2018-06-30 |
$-0.19B |
|
inf% |
| 2018-03-31 |
$-0.18B |
|
inf% |
| 2017-12-31 |
$-0.11B |
|
-2038.10% |
| 2017-09-30 |
$-0.10B |
|
-2040.00% |
| 2017-06-30 |
$-0.09B |
|
-1800.00% |
| 2017-03-31 |
$-0.07B |
$0.02B |
-1440.00% |
| 2016-12-31 |
$-0.06B |
$-0.00B |
24400.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.059B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
